According to our latest research study on “Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product and service, technology, and end user,” the human leukocyte antigen (HLA) testing market size is projected to reach US$ 1,155.65 million by 2028 from US$ 697.74 million in 2021; it is estimated to grow at a CAGR of 7.5% from 2022 to 2028. The report highlights trends prevailing in the market and factors governing the growth of the market.

Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants. The facts mentioned above boost the demand and availability of human leukocyte antigen (HLA) testing market, thus driving the entry of more players into the human leukocyte antigen (HLA) testing market

Increasing Government Funding for Organ Donation Creates Opportunities for Human Leukocyte Antigen (HLA) Testing Market Players Living organ donations and deceased organ donations (DCD) are the two types of organ donations. The demand for both types of organ donations is rising day by day due to the elevating cases of chronic illnesses. According to the US Human Resource and Service Administration (HRSA), ~21 people die waiting for an organ in the US every day. More than 107,380 men, women, and children in the country await life-saving organ transplants. Additionally, as per the Ministry of Health and Family Welfare (MoHFW) of the Government of India, annually 500,000 people die because of non-availability of organs, 200,000 people die due to liver disorders, and 50,000 people die because of heart disease. Moreover, 150,000 people await a kidney transplant, but only 5,000 get kidneys for transplantation. These numbers indicate the need for organ donors, which is much greater than the actual number of donations. Similar scenarios have been found in other nations of the world.

Get Sample Report of Human Leukocyte Antigen (HLA) Testing Market Report @  https://www.theinsightpartners.com/sample/TIPRE00021578/

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com